BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  valstar: 2     
HTML
100%
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Company Announces Revised Operating Plan to Respond to NEBIDO Delay LEXINGTON, Mass., June 30 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.

today announced that it has received an approvable letter from the U.S.

Food and Drug...

KOTA Territory News:  Jun 30 2008 4:56PM
Matching: valstar 		Find similar documents
HTML
100%
Indevus Announces Management Changes
Company Begins Process to Restore Shareholder Value Following NEBIDO(R) Delay LEXINGTON, Mass., June 12 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.

today announced that Glenn L.

Cooper, MD, its chairman and chief executive...

KOTA Territory News:  Jun 12 2008 5:38PM
Matching: valstar 		Find similar documents
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.